We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




AI Tool Maps Early Risk Patterns in Bloodstream Infections

By HospiMedica International staff writers
Posted on 24 Mar 2026

Bloodstream infections can deteriorate rapidly and carry high mortality, especially in immunocompromised patients. More...

Clinicians need reliable early risk stratification to prioritize monitoring and organ support. A new study shows that artificial intelligence (AI) can group patients into clinically meaningful risk patterns within the first 48 hours of diagnosis. The approach aims to help teams identify those most likely to require escalated care.

Researchers at Houston Methodist Research Institute (Houston, TX, USA) used an unsupervised machine learning approach to stratify bloodstream infection (BSI) patients using data from the first 48 hours after diagnosis. From more than 15,000 records, the model identified three patient clusters to inform early risk assessment. The analysis was designed to assist clinicians in recognizing previously unseen infection patterns.

Investigators extracted 27 characteristics from electronic health records (EHRs) after BSI was confirmed in microbiology databases. Uniform Manifold Approximation and Projection (UMAP) reduced dimensionality, and k-means++ clustering delineated distinct phenotypes. Each cluster was further categorized as solid organ transplant (SOT) or non-SOT, and clinical characteristics and outcomes were evaluated.

The highest‑risk cluster included older, predominantly male patients who more often required ventilator and vasopressor support and encompassed transplant recipients. These individuals are especially susceptible to infection, with one in 10 developing an infection in the first year after transplant and mortality reported as high as 60%. The other two clusters appeared clinically similar at baseline but diverged in outcomes, with one milder and the other associated with greater severity and mortality.

The research was published in the American Journal of Transplantation (2026). Next steps include validating the approach in external healthcare systems to confirm reproducibility and refining the methodology to inform clinical decision-making and patient outcomes. 

"Our model turns routine early data into a risk map clinicians can use immediately. This gives us a new way to understand and predict how sick a patient might become. If we can identify high-risk patients sooner, we can act sooner," said Stefano Casarin, Ph.D., assistant professor in the Center for Precision Surgery at Houston Methodist Research Institute.

Related Links
Houston Methodist Research Institute


New
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Surgical Dressing
ALLEVYN Ag+ SURGICAL
New
Pediatric Mask
Respire SOFT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.